Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$12.75−0.40 (-3.04%)
Close on Nov 16, 2026Market cap $86.56MP/E –Yield –
Eloxx Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Eloxx Pharmaceuticals's enterprise value was -$9.45M on Nov 11, 2026, against $6.41M a year earlier. Over the last 5 years it ranged from -$9.45M to $633.11M, with a median of $27.83M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$9.45M | -247.4% |
| 2025 | Dec 31, 2025 | $6.41M | +137.6% |
| 2024 | Dec 31, 2024 | $2.70M | -90.8% |
| 2023 | Dec 29, 2023 | $29.26M | -6.2% |
| 2022 | Dec 30, 2022 | $31.21M | -95.1% |
| 2021 | Dec 31, 2021 | $633.11M | -63.6% |
| 2020 | Dec 31, 2020 | $1.74B | -45.4% |
| 2019 | Dec 31, 2019 | $3.19B | -30.5% |
| 2018 | Dec 31, 2018 | $4.58B | +154.3% |
| 2017 | Dec 29, 2017 | $1.80B | – |
See a number that looks wrong?